全文获取类型
收费全文 | 1009篇 |
免费 | 38篇 |
国内免费 | 78篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 42篇 |
妇产科学 | 16篇 |
基础医学 | 98篇 |
口腔科学 | 15篇 |
临床医学 | 145篇 |
内科学 | 191篇 |
皮肤病学 | 22篇 |
神经病学 | 26篇 |
特种医学 | 363篇 |
外科学 | 32篇 |
综合类 | 20篇 |
预防医学 | 25篇 |
眼科学 | 1篇 |
药学 | 78篇 |
肿瘤学 | 49篇 |
出版年
2023年 | 2篇 |
2021年 | 3篇 |
2020年 | 2篇 |
2019年 | 1篇 |
2018年 | 10篇 |
2017年 | 7篇 |
2016年 | 9篇 |
2015年 | 9篇 |
2014年 | 15篇 |
2013年 | 17篇 |
2012年 | 23篇 |
2011年 | 11篇 |
2010年 | 26篇 |
2009年 | 40篇 |
2008年 | 22篇 |
2007年 | 80篇 |
2006年 | 19篇 |
2005年 | 23篇 |
2004年 | 12篇 |
2003年 | 21篇 |
2002年 | 13篇 |
2001年 | 19篇 |
2000年 | 17篇 |
1999年 | 21篇 |
1998年 | 67篇 |
1997年 | 74篇 |
1996年 | 51篇 |
1995年 | 69篇 |
1994年 | 37篇 |
1993年 | 37篇 |
1992年 | 18篇 |
1991年 | 20篇 |
1990年 | 17篇 |
1989年 | 37篇 |
1988年 | 36篇 |
1987年 | 23篇 |
1986年 | 28篇 |
1985年 | 47篇 |
1984年 | 18篇 |
1983年 | 12篇 |
1982年 | 25篇 |
1981年 | 14篇 |
1980年 | 24篇 |
1979年 | 4篇 |
1978年 | 4篇 |
1977年 | 15篇 |
1976年 | 15篇 |
1975年 | 9篇 |
1970年 | 1篇 |
1906年 | 1篇 |
排序方式: 共有1125条查询结果,搜索用时 187 毫秒
71.
72.
Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics 总被引:1,自引:0,他引:1
Antonescu C Bischof Delaloye A Kosinski M Monnin P Schaffland AO Ketterer N Grannavel C Kovacsovics T Verdun FR Buchegger F 《European journal of nuclear medicine and molecular imaging》2005,32(8):943-951
Purpose It is generally assumed that the biodistribution and pharmacokinetics of radiolabelled antibodies remain similar between dosimetric and therapeutic injections in radioimmunotherapy. However, circulation half-lives of unlabelled rituximab have been reported to increase progressively after the weekly injections of standard therapy doses. The aim of this study was to evaluate the evolution of the pharmacokinetics of repeated 131I-rituximab injections during treatment with unlabelled rituximab in patients with non-Hodgkins lymphoma (NHL).Methods Patients received standard weekly therapy with rituximab (375 mg/m2) for 4 weeks and a fifth injection at 7 or 8 weeks. Each patient had three additional injections of 185 MBq 131I-rituximab in either treatment weeks 1, 3 and 7 (two patients) or weeks 2, 4 and 8 (two patients). The 12 radiolabelled antibody injections were followed by three whole-body (WB) scintigraphic studies during 1 week and blood sampling on the same occasions. Additional WB scans were performed after 2 and 4 weeks post 131I-rituximab injection prior to the second and third injections, respectively.Results A single exponential radioactivity decrease for WB, liver, spleen, kidneys and heart was observed. Biodistribution and half-lives were patient specific, and without significant change after the second or third injection compared with the first one. Blood T1/2, calculated from the sequential blood samples and fitted to a bi-exponential curve, was similar to the T1/2 of heart and liver but shorter than that of WB and kidneys. Effective radiation dose calculated from attenuation-corrected WB scans and blood using Mirdose3.1 was 0.53+0.05 mSv/MBq (range 0.48–0.59 mSv/MBq). Radiation dose was highest for spleen and kidneys, followed by heart and liver.Conclusion These results show that the biodistribution and tissue kinetics of 131I-rituximab, while specific to each patient, remained constant during unlabelled antibody therapy. RIT radiation doses can therefore be reliably extrapolated from a preceding dosimetry study. 相似文献
73.
Tu'meh SS; Tracy DA; Wynne J; Konstam MA; Kozlowski JF; Neumann AL; Holman BL 《Radiology》1982,145(2):463-466
The authors describe a simple technique for diagnosis of tricuspid regurgitation. Red blood cells were labeled in vivo with 99mTc and 22 patients were studied with ECG-gated blood-pool imaging of the liver. A single region of interest was manually drawn around the liver and a time-activity curve obtained. The per cent change in liver counts during the cardiac cycle was found to be significantly higher in the 12 patients with tricuspid regurgitation (Group I) (mean, 4.04 +/- 1.6%; range, 1.3-21.4%) compared with the 10 controls (Group II) (mean, 0.35 +/- 0.16%; range, 0.013-1.3%) (p less than 0.05). Using a 1% change in liver counts as the criterion of a positive study, all 12 cases in Group I were diagnosed correctly, but there was one false positive in Group II; thus the sensitivity was 100% and the specificity 90%. 相似文献
74.
Postembolic colonic infarction 总被引:12,自引:0,他引:12
75.
Schaffland AO Delaloye AB Kosinski M Dupertuis YM Buchegger F 《Nuclear medicine communications》2004,25(5):461-468
BACKGROUND AND METHODS: 5-Iodo-2'-deoxyuridine (IdUrd) radiolabelled with the positron emitter I or with the gamma and Auger electron emitters I or I has been proposed for cancer diagnosis and therapy. We modified the synthesis to reliably obtain [I]IdUrd and [I]IdUrd by using an Iodogen supported destannylation reaction of 5-(tri-n-butylstannyl)-2'-deoxyuridine (Bu3SndUrd) which meets the requirements for good laboratory practice (GLP) and good clinical practice (GCP). A method of purification was developed to eliminate by-products as well as any unreacted starting material. RESULTS: [I]IdUrd, which originated from a trace of iodide in the Bu3SndUrd precursor, was identified as the unknown by-product reported for this method. This trace could be eliminated by modified purification of Bu3SndUrd. Stabilization of pH was essential for unequivocal identification of radiolabelled IdUrd and possible degradation products in the different systems tested for quality control. Biodistribution in tumour bearing nude mice was measured as early as 3 and 6 h after i.v. injection of [I]IdUrd. This compound showed high and specific activity uptake in tumour and dividing tissues when combined with 5-fluoro-2'-deoxyuridine pre-treatment. Uptake was specifically inhibited by injection of excess thymidine. 相似文献
76.
Radioimmunotherapy (RIT) represents an exciting new therapeutic option for the treatment of B-cell non-Hodgkin's lymphoma (NHL), emerging at a time when significant advances have been made in NHL classification, molecular genetics and treatment. Despite recent treatment advances, including the use of fludarabine phosphate-based combination chemotherapies, able to eradicate minimal residual disease, there remains much room for improvement. The incorporation of RIT into treatment schedules is an attractive option to exploit the extreme sensitivity of lymphoma cells to irradiation. In this supplement, we examine the potential future roles for RIT in the light of past and present therapies, existing RIT clinical data and the unique attributes of radiolabeled monoclonal antibodies. 相似文献
77.
78.
银杏叶制剂对心绞痛患者的抗氧化和抗脂质过氧化作用 总被引:15,自引:0,他引:15
目的:探讨银杏叶制剂对心绞痛患者的抗氧化和抗脂质过氧化作用。方法:检测了78例心绞痛患者经银杏叶制剂“天宝宁”治疗前后的血浆维生素C(P-VC)、维生素E(P-VE)、β-胡萝卜素(P-β-CAR)、过氧化脂质(P-LPO)以及红细胞超氧化物歧化酶(E-SOD)、过氧化氢酶(E-CAT)、谷胱甘肽过氧化物酶(E-GSH-PX)、过氧化脂质(E-LPO)值。结果:与治疗前比较,治疗后的P-VC、P- 相似文献
79.
Mercado S; Hunter DW; Castaneda-Zuniga WR; Amplatz K; Young AT; Cardella JF; Lange PH; Hulbert JC; Reddy P 《Radiology》1986,158(1):207-209
Percutaneous nephrostolithotomy, which can require a double puncture, is presently the method of choice in our institution for the removal of renal stones. Patients that underwent this procedure were evaluated to identify the possible reasons for the double puncture. Of 200 patients evaluated, 14 needed a second tract. The three variables that determined whether a second puncture was needed, in order of importance, were number and size of the stones, with second tracts needed in patients with multiple stones and staghorn calculi; anatomical variations of the renal collecting system itself, with bifid systems the most significant anatomic variation; and the dexterity of the radiologist in performing the puncture and the ability of the urologist to extract the stone. Second tracts were needed more frequently in patients who presented with stones in both the lower and middle poles of the collecting systems. 相似文献
80.
Darcy MD; Cardella JF; Hunter DW; Smith TP; Castaneda-Zuniga WR; Lund G; Amplatz K 《Radiology》1986,161(3):611-614
The Amplatz retrievable vena caval filter was designed in an attempt to decrease complications associated with the placement of Mobin-Uddin or Kimray-Greenfield filters. The design allows percutaneous retrieval, thus expanding application of the filter to situations requiring temporary prophylaxis against pulmonary embolism. Filters have been placed in 16 patients, nine (56%) for prophylactic purposes. All filters were easily inserted percutaneously. Complications occurred in three patients; these included complete thrombosis of the inferior vena cava below the filter, misplacement of one filter into the pericaval retroperitoneal tissue, and development of thrombus cranial to the filter. With the current introduction system, the possibility of filter misplacement has been essentially eliminated. No patient experienced symptoms suggestive of pulmonary embolism after filter insertion. One filter retrieval has been performed, with no complications. 相似文献